Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC, 45700 [2020-16397]
Download as PDF
<![CDATA[
45700
Federal Register / Vol. 85, No. 146 / Wednesday, July 29, 2020 / Notices
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on June 5, 2020, Euticals
Inc., 2460 W Bennett Street, Springfield,
Missouri 65807–1229, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
ADDRESSES:
Controlled substance
Gamma Hydroxybutyric
Acid.
Amphetamine ................
Lisdexamfetamine .........
Methylphenidate ............
Phenylacetone ...............
Methadone .....................
Methadone intermediate
Oripavine .......................
Tapentadol .....................
Drug
code
Schedule
Drug
code
Amphetamine ................
Tapentadol .....................
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–16397 Filed 7–28–20; 8:45 am]
BILLING CODE 4410–09–P
1100
1205
1724
8501
9250
9254
9330
9780
II
II
II
II
II
II
II
II
[OMB Number 1190–NEW]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Generic
Clearance for Pilot and Field Studies
for Community Relations Service Data
Collection Activities
[FR Doc. 2020–16401 Filed 7–28–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–687]
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 28, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on May 21, 2020, Siegfried
USA, LLC, 33 Industrial Park Road,
Pennsville, New Jersey 08070–3244,
applied to be registered as a bulk
17:23 Jul 28, 2020
Jkt 250001
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for sale to its customers.
DEPARTMENT OF JUSTICE
DATES:
Schedule
1100
9780
I
William T. McDermott,
Assistant Administrator.
VerDate Sep<11>2014
Controlled
substance
2010
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
No other activities for these drug codes
are authorized for this registration.
ACTION:
manufacturer of the following basic
class(es) of controlled substances:
Community Relations Service,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Community Relations Service
(CRS), intends to request approval from
the Office of Management and Budget
(OMB) for a generic information
collection clearance that will allow CRS
to conduct a variety of participant
feedback studies. CRS will submit the
request for review and approval in
accordance with the Paperwork
Reduction Act of 1995. Over the next
three years, CRS anticipates collecting
program impact evaluation data for
reassessing ongoing programs across
several areas within community
outreach. The purpose of these
collections is to gather feedback from
participants who attended CRS
programs and to use that information to
measure the impact of the programs.
This work may entail redesigning and/
or modifying existing programs based
upon received feedback. CRS envisions
using surveys, interviews, and other
electronic data collection instruments.
DATES: Comments are encouraged and
will be accepted for 60 days until
September 28, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
SUMMARY:
PO 00000
Frm 00127
Fmt 4703
Sfmt 4703
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Community Relations
Service, including whether the
information will have practical utility.
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used.
—Evaluate whether (and if so, how) the
quality, utility, and clarity of the
information to be collected can be
enhanced.
—Minimize the burden of the collection
of information on those who are to
respond, including using appropriate
automated, electronic, mechanical, or
other technological collection
techniques or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
New Generic Information Collection
Request.
(2) The Title of the Form/Collection:
Generic Clearance for Community
Relations Service Program Impact
Evaluations.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form numbers not available for generic
clearance. The applicable component
within the Department of Justice is the
Community Relations Service.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Participants of CRS programs
in relevant jurisdictional fields;
individuals; facilitators; state and local
law enforcement, government officials,
faith leaders, and community leaders;
students; school administrators; and
representatives of advocacy
organizations.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: We estimate that
approximately 80–90 respondents will
be involved in program impact
evaluations conducted under this
clearance over the requested 3-year
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 85, Number 146 (Wednesday, July 29, 2020)]
[Notices]
[Page 45700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16397]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-687]
Bulk Manufacturer of Controlled Substances Application: Siegfried
USA, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before September 28,
2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 21, 2020, Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070-3244, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amphetamine............................ 1100 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for sale to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-16397 Filed 7-28-20; 8:45 am]
BILLING CODE 4410-09-P
